WHO South-East Asia Region Commits to Ending Tuberculosis

Member states of the World Health Organisation South-East Asia Region committed to integrated actions targeting tuberculosis gaps during the 79th Session of the WHO Regional Committee for South-East Asia, focusing on early detection, financial protections, and vaccine preparedness. According to WHO data, the region accounted for roughly 34 percent of new global tuberculosis cases in … Read more

Dexamethasone Calms Lung Inflammation Without Harming Immunity

Researchers at Trinity College Dublin and St. James’s Hospital have demonstrated that dexamethasone, a commonly prescribed anti-inflammatory steroid, reduces harmful inflammation triggered by Mycobacterium avium without weakening the ability of human immune cells to control the infection, according to a study published in the Journal of Infectious Diseases. Understanding Nontuberculous Mycobacterial Disease and Treatment Challenges … Read more

South Africa Prepares for Potential New Adult TB Vaccine

South Africa has initiated preparatory measures for the potential introduction of the M72/AS01E tuberculosis vaccine, marking a significant step toward addressing a disease that has lacked a new vaccine in over a century. The Department of Health is coordinating with international partners to ensure that if current Phase 3 clinical trials prove successful, the country … Read more

New Battery-Powered Device Detects Bundibugyo Ebola in 30 Minutes

Researchers at Osaka Metropolitan University (OMU), in partnership with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) in the Democratic Republic of the Congo, are developing a portable, rapid diagnostic system to detect the Bundibugyo virus (BDBV). The project, supported by the Global Health Innovative Technology Fund (GHIT Fund), aims to provide field-ready, … Read more

PAC-MAN and AI Team Up to Fight the World’s Deadliest Infection

Tuberculosis claimed 1.23 million lives in 2024, remaining one of the world’s deadliest infectious diseases due to the bacterium’s highly selective outer shell, the mycomembrane. Researchers at the University of Massachusetts Amherst have now developed a paired screening and machine-learning approach to identify which drug compounds can successfully penetrate this barrier, according to findings published … Read more

New Techniques Accelerate Tuberculosis Drug Discovery

Researchers at the University of Massachusetts Amherst have developed an artificial intelligence model called MycoPermeNet to accelerate the discovery of tuberculosis drugs. By combining this AI with a high-throughput screening technique known as PAC-MAN, the team can predict which chemical compounds can penetrate the bacterium’s unique mycomembrane, potentially speeding up the search for effective treatments … Read more

BCG Vaccine May Alter Human Brain Immunity

The Bacillus Calmette-Guérin (BCG) vaccine, typically used to prevent tuberculosis, may remodel the brain’s immune environment to potentially lower Alzheimer’s disease risk, according to research published in Communications Medicine. A year-long study led by Mass General Brigham investigators found the vaccine increased immune cell responsiveness and altered Alzheimer’s-related biomarkers in older adults without pre-existing pathology. … Read more

Addison’s Disease: How Skin Darkening Led to a Life-Saving Diagnosis

Hyperpigmentation as a Clinical Red Flag Unexplained skin darkening on the hands, feet, gums, and tongue can serve as the primary diagnostic indicator of Addison’s disease, a rare endocrine disorder. According to a case report published in the journal Skin on June 4, 2026, clinicians identified this specific hyperpigmentation in a 24-year-old patient two years … Read more

India’s Tuberculosis Strategy: Progress and Ongoing Gaps

India is transitioning its national tuberculosis strategy from basic disease control to total elimination through the National Tuberculosis Elimination Program (NTEP). According to a review published in the journal Zoonoses, this shift addresses longstanding barriers including drug-resistant TB, HIV co-infection, and fragmented private sector regulation that have historically hindered mortality reduction efforts. How has India’s … Read more

Untargeted Metabolomics Identifies New Biomarkers for Latent Tuberculosis

New Frontiers in Diagnosing Latent Tuberculosis Infection Diagnosing latent tuberculosis infection (LTBI) has long been a clinical challenge, primarily because there is no single gold-standard test available to practitioners. Recent research published in BIO Integration suggests that the future of TB diagnostics may lie in the field of metabolomics—the study of chemical processes involving metabolites. … Read more